MARK D GAUGHAN

Allopathic & Osteopathic Physicians|Dermatology DURANGO, CO NPI 1790792851

General Payments — all program years on this page

$2,044.38

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 101
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $491.47 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $417.9719
Education $73.501

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $161.689
Regeneron Healthcare Solutions, Inc. $146.474
Lilly USA, LLC $56.342
UCB, Inc. $47.502
GENZYME CORPORATION $38.531
NOVARTIS PHARMACEUTICALS CORPORATION $23.211
Amgen Inc. $17.741

By program year

Program yearAmountRecords
2018 $444.4819
2019 $272.9815
2020 $57.313
2021 $152.518
2022 $265.5716
2023 $360.0620
2024 $491.4720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086883453 Novartis Pharmaceuticals Corporation $23.21 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781511 ABBVIE INC. $19.87 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781513 ABBVIE INC. $5.95 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781515 ABBVIE INC. $8.78 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781517 ABBVIE INC. $33.54 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781519 ABBVIE INC. $22.96 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781521 ABBVIE INC. $14.55 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781523 ABBVIE INC. $19.82 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781525 ABBVIE INC. $22.72 11/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103781527 ABBVIE INC. $13.49 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114053483 Regeneron Healthcare Solutions, Inc. $29.54 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114053485 Regeneron Healthcare Solutions, Inc. $14.30 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114053487 Regeneron Healthcare Solutions, Inc. $73.50 10/29/2024 Education Undisputed 01/23/2026 View at CMS
1114053489 Regeneron Healthcare Solutions, Inc. $29.13 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117258567 Amgen Inc. $17.74 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135152396 Lilly USA, LLC $31.39 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135162501 Lilly USA, LLC $24.95 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139644336 GENZYME CORPORATION $38.53 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143074427 UCB, Inc. $20.89 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143074429 UCB, Inc. $26.61 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.